A Two-Period Open-Label, Single-Dose Crossover Study in Healthy Volunteers to Evaluate the Drug-Drug Interaction Between Cimetidine and Inhaled Extrafine CHF 5993.
about
A Two-Period Open-Label, Single-Dose Crossover Study in Healthy Volunteers to Evaluate the Drug-Drug Interaction Between Cimetidine and Inhaled Extrafine CHF 5993.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A Two-Period Open-Label, Singl ...... nd Inhaled Extrafine CHF 5993.
@en
A Two-Period Open-Label, Singl ...... nd Inhaled Extrafine CHF 5993.
@nl
type
label
A Two-Period Open-Label, Singl ...... nd Inhaled Extrafine CHF 5993.
@en
A Two-Period Open-Label, Singl ...... nd Inhaled Extrafine CHF 5993.
@nl
prefLabel
A Two-Period Open-Label, Singl ...... nd Inhaled Extrafine CHF 5993.
@en
A Two-Period Open-Label, Singl ...... nd Inhaled Extrafine CHF 5993.
@nl
P2093
P2860
P1476
A Two-Period Open-Label, Singl ...... nd Inhaled Extrafine CHF 5993.
@en
P2093
Annamaria Muraro
Daniela Acerbi
Fabrizia Mariotti
Giorgia Ciurlia
Luca Spaccapelo
P2860
P2888
P304
P356
10.1007/S13318-016-0345-2
P577
2016-05-21T00:00:00Z